KONG GARHENG received a stock award from XERIS BIOPHARMA HOLDINGS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/5/2026ACC: 0001867096-26-000041
Director
Since Oct 2021
+57.19K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
57.19K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+24.19K
Price / share
—
Trade value
—
% of position
11.3%
6/4/2026
214.14K→238.34K
Total
Net shares
+24.19K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/4/2026 | A · Award | +24.19K | — | — | 11.3% | 214.14K | 238.34K |
| Total | +24.19K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
33K shares
Shares
+33K
Strike price
6.15
Held after
33K
Exercisable
—
6/4/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock33K shares | 6/4/2026 | A · Award | +33K | 6.15 | — | 33K |